Advertisement
Advertisement

ALEC

ALEC logo

Alector, Inc. Common Stock

1.93
USD
Sponsored
+0.14
+7.54%
Jun 25, 11:56 UTC -4
Open

Alector, Inc. Common Stock Profile

About

Alector Inc. is a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. Its product portfolio includes AL001, AL101, Al002 and AL003 which are in clinical stage. Alector Inc. is headquartered in South San Francisco, California.

Info & Links

CEO

Arnon Rosenthal

Headquarters

131 OYSTER POINT BLVD., SUITE 600
SOUTH SAN FRANCISCO, CA 94080, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.alector.com

Auditor

Ernst & Young LLP

Share holders

6

Employees

103

Alector, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

213.72M

Enterprise Value

146.53M

Enterprise Value/EBITDA(ttm)

-1.12

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

12.59

Price to Book(mrq)

8.55

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-679.16%

Profit Margin(ttm)

-787.53%

Return on Equity(ttm)

-224.96%

Return on Invested Capital(ttm)

-221.43%

Return on Assets(ttm)

-41.03%

Income Statement

Revenue(ttm)

18.42M

Revenue Per Share(ttm)

0.17

Gross Profit(ttm)

18.42M

EBITDA(ttm)3

-131.25M

Net Income Available to Common(ttm)

-125.39M

Diluted EPS(ttm)

-1.39

Share Statistics

Beta (5Y Monthly)

0.58

52-Week Change

29.19%

S&P 500 52-Week Change

21.18%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

111.03M

Dividend Yield

0.00%

Float4

99.66M

% Held by Insiders

9.70%

% Held by Institutions

85.83%

Balance Sheet

Total Cash(mrq)

206.51M

Total Cash Per Share(mrq)

1.86

Total Debt(mrq)

9.77M

Total Debt/Equity(mrq)

31.61%

Current Ratio(mrq)

3.83%

Quick Ratio(mrq)

3.83%

Book Value Per Share(mrq)

0.28

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.79

Free Cash Flow(ytd)

-184.07M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement